Effect of pharmaceutical intervention on medication adherence and blood pressure control in treated hypertensive patients: Rationale, design and methods of the AFenPA pilot study

Ars Pharmaceutica

Volumn 52, Issue 4, 2014, Pages 29-38

  Fikri Benbrahim, N ^a   Sabater Hernandez D ^a   Fikri Benbrahim, O ^b   Faus, M J ^a   Martinez Martinez F ^a   Gonzalez Segura Alsina D ^c  

^a UNIVERSITY OF GRANADA   (Spain)

^b La Mancha Centro Hospital Complex   (Spain)

^c Medical Department Almirall SA ^*  (Spain)

Author keywords

Adherence; Community pharmacy services; Home blood pressure monitoring; Hypertension; Intervention

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACY; PILOT STUDY; QUASI EXPERIMENTAL STUDY;

EID: 84887618747     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Banegas JR, Rodriguez-Artalejo F, Ruilope LM, Graciani A, Luque M, De La Cruz-Troca JJ, Garcia-Robles R, Tamargo J, Rey-Calero J: Hypertension magnitude and management in the elderly population of Spain. J Hypertens. 2002;20(11):2157-2164.
2. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfeld MJ, Cifkova R, Clement D, Coca A, Dominiczak A et al: Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009, 27(11):2121-2158.
3. Banegas JR, Segura J, Sobrino J, Rodriguez-Artalejo F, De La Sierra A, De La Cruz JJ, Gorostidi M, Sarria A, Ruilope LM: Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49(1):62-68.
4. Collins R, MacMahon S: Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994;50(2):272-298.
5. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, Carrell D, Tyll L, Larson EB, Thompson RS: Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857-2867.
6. Zillich AJ, Sutherland JM, Kumbera PA, Carter BL: Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med. 2005;20(12):1091-1096.
7. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report oft the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560-2572.
8. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertens. 1999;17(2):151-183.
9. Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD et al: The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol. 2010;26(5):249-258.
10. Carter BL, Elliott WJ: The role of pharmacists in the detection, management, and control of hypertension: a national call to action. Pharmacotherapy. 2000;20(2):119-122.
11. Grupo de Consenso. Documento de Consenso en Atención Farmacéutica. 2001;42:223-243.
12. Ars Pharmaceutica. 2001;42(3-4):223-243.
13. Comité de Consenso. Foro de Atención Farmacéutica. Documento de Consenso. 2008.
14. Hepler CD, Strand LM: Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-543.
15. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M: Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241-253.
16. Machado M, Bajcar J, Guzzo GC, Einarson TR: Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770-1781.
17. Carter BL, Rogers M, Daly J, Zheng S, James PA: The potency of team-based care interventions for hypertension: a metaanalysis. Arch Intern Med. 2009;169(19):1748-1755.
18. Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C: Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother. 2004;38(12):2023-2028.
19. Borenstein JE, Graber G, Saltiel E, Wallace J, Ryu S, Archi J, Deutsch S, Weingarten SR: Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003;23(2):209-216.
20. Vivian EM: Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002;22(12):1533-1540.
21. Taylor CT, Byrd DC, Krueger K: Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm. 2003;60(11):1123-1129.
22. Carter BL, Zillich AJ: Pharmaceutical care services for patients with hypertension. Ann Pharmacother. 2003;37(9):1335-1337.
23. De Castro MS, Fuchs FD, Santos MC, Maximiliano P, Gus M, Moreira LB, Ferreira MB: Pharmaceutical care program for patients with uncontrolled hypertension. Report of a doubleblind clinical trial with ambulatory blood pressure monitoring. Am J Hypertens. 2006;19(5):528-533.
24. Tisdale JE: Role of the pharmacist in managing hypertension in patients with diabetes. Am J Health Syst Pharm. 2006;63(12):1129.
25. Von Muenster SJ, Carter BL, Weber CA, Ernst ME, Milchak JL, Steffensmeier JJ, Xu Y: Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci. 2008;30(1):128-135.
26. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T: Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010; (3): CD005182.
27. Lai LL: Community pharmacy-based hypertension diseasemanagement program in a Latino/Hispanic-American population. Consult Pharm. 2007;22(5):411-416.
28. Cappuccio FP, Kerry SM, Forbes L, Donald A: Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004;329(7458):145.
29. Stergiou G, Mengden T, Padfeld PL, Parati G, O'Brien E: Self monitoring of blood pressure at home. BMJ. 2004;329(7471):870-871.
30. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D: Call to action on use and reimbursement for home blood pressure monitoring: a joint scientifc statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):10-29.
31. McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfeld S, Kaambwa B, Banting M, Bryan S, Little P et al: Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163-172.
32. Agarwal R, Bills JE, Hecht TJ, Light RP: Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and metaanalysis. Hypertension. 2011;57(1):29-38.
33. Parati G, Stergiou GS, Asmar R, Bilo G, De Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T et al: European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24(12):779-785.
34. Lopez LM, Taylor JR: Home blood pressure monitoring: point-of-care testing. Ann Pharmacother. 2004;38(5):868-873.
35. Matowe WC, Abahussain EA, Awad A, Capps PA: Self-monitoring of blood pressure and the role of community pharmacists in Kuwait. Med Princ Pract. 2008;17(1):27-31.
36. Machin D, Campbell MJ: Statistical tables for design of clinical trials. Chapter 3. Comparing two binomials propotions. Offces Oshey Mead, Oxford OX2OEL edition; 1987.
37. Simpson SH, Johnson JA, Biggs C, Biggs RS, Kuntz A, Semchuk W, Taylor JG, Farris KB, Tsuyuki RT: Practice-based research: lessons from community pharmacist participants. Pharmacotherapy. 2001;21(6):731-739.
38. Bonso E, Dorigatti F, Saladini F, Palatini P: Validation of the Visomat Comfort form device for home blood pressure measurement according to the International Protocol. Blood Press Monit. 2010;15(1):63-66.
39. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfeld P, Palatini P, Parati G et al: Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23(4):697-701.
40. Piñeiro F, Gil V, Donis M, Orozco D, Pastor R, Merino J: Validez de 6 métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en la hipertensión arterial. Aten Primaria. 1997;19(7):372-376.
41. Gil V, Muñoz C, Martínez JL, Belda J, Soriano JE, J. M: [Factors involved in the hypertensive patient non-compliance with treatment]. Med Clin (Barc). 1994;102(2):50-53.
42. Prado JC, Jr., Kupek E, Mion D, Jr.: Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens. 2007;21(7):579-584.